21.57
Pulse Biosciences Inc Azioni (PLSE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
206.98%
0.264
|
0.086 | - | - | - |
| Cost Of Revenue |
6.81%
0.26
|
0.279 | - | - | - |
| Gross Profit |
102.07%
0.004
|
-0.193 | - | - | - |
|
|
9.50%
18.26
|
20.17 | - | - | - |
| Benefits Costs and Expenses |
741.58%
-131.22
|
20.45 | - | - | - |
| Costs And Expenses |
9.47%
18.52
|
20.45 | 20.27 | 18.04 | 20.26 |
| Operating Income/Loss |
10.38%
-18.25
|
-20.37 | -20.27 | -18.04 | -20.26 |
| Nonoperating Income/Loss |
16.50%
0.82
|
0.982 | 1.107 | 1.249 | 0.876 |
| Income/Loss From Continuing Operations Before Tax |
745.58%
131.49
|
-20.37 | -19.17 | -16.80 | -19.39 |
| Income/Loss From Continuing Operations After Tax |
761.07%
128.15
|
-19.39 | -19.17 | -16.80 | -19.39 |
|
|
10.07%
-17.43
|
-19.39 | -19.17 | -16.80 | -19.39 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.80%
0.1323
|
67.39 | 67.28 | 67.13 | 1.229 |
| Basic Earnings Per Share |
10.34%
-0.26
|
-0.29 | -0.28 | -0.25 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):